Suscríbete a nuestras actualizaciones (en inglés) aquí para estar al tanto de los últimos avances y actualizaciones en materia de propiedad intelectual.
As consumers increasingly choose skincare based on ingredients like retinol and niacinamide, companies may need to rethink patent strategies, placing greater emphasis on manufacturing innovation.
The enhanced UK-Switzerland FTA provides greater certainty on IP rights and exclusivity, supports cross-border collaboration and investment and streamlines talent mobility for pharma and biotech innov
A patent does not automatically grant the right to commercialise. Discover how competitor patent watching helps deep-tech businesses identify risks, monitor rivals and prepare for future freedom-to-op
The UAE now permits trade mark filings for alcoholic beverages in Class 33 and beer in Class 32, aligning more closely with NICE Classification standards and offering stronger protection for brands.
A comparison of UPC and EPO jurisdiction, examining early UPC decisions on competence, long-arm jurisdiction, infringement, validity challenges and cross-border patent disputes.
Discover why some of the most valuable patents in advanced materials, batteries, chemicals and green technologies emerge during scale-up from lab success to commercial manufacturing.
Learn the key differences between EPO oppositions and UPC revocation actions, from filing windows and procedural timelines to costs, scope and strategic considerations when challenging European patent
From ownership and licensing to patents and publications, effective IP strategy is vital for university spin-outs. Learn how to protect innovation and support commercial success.
The Enlarged Board's G 1/25 decision confirms description amendments are only needed where unresolved inconsistencies with the claims cause non-compliance with the EPC.
An EPO Board of Appeal decision reinforces the lessons of G 1/19. Careful claim drafting for computer-modelling inventions is essential to establish inventive step and preserve amendment options.
As solid-state battery patent filings surge, start-ups must protect innovation while managing freedom-to-operate risks. Discover how a robust IP strategy can support investment, growth and commercial
A recent EPO Board of Appeal decision confirms that applicants can correct errors in grant texts through appeal, but may still have to pay the appeal fee if they failed to identify the mistake earlier
A recent EPO appeal decision highlights the risks of claim alternatives, confirming that each alternative must independently meet sufficiency requirements.
Learn how chemistry start-ups can avoid 10 common patent portfolio mistakes and build an IP strategy that protects innovation, attracts investors and supports long-term commercial success.
Explore how major biotech and pharmaceutical jurisdictions approach double patenting and divisional applications, and discover strategies for building stronger global patent portfolios.
A recent UPC decision highlights the risks of delaying an opt out. Learn why early action may be essential to keep European patents outside UPC jurisdiction.
Boult is pleased to announce that it has been ranked as “Outstanding” for non-contentious patent matters by the World Intellectual Property Review (WIPR) for 2026.
Boult is proud to be recognised in Lexology Index: IP 2026, with Dr Catherine Wolfe named a Global Elite Thought Leader and multiple partners ranked across the prestigious report.
Suscríbete a nuestras actualizaciones (en inglés) aquí para estar al tanto de los últimos avances y actualizaciones en materia de propiedad intelectual.